{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:01:09Z","timestamp":1782954069462,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009996","name":"Sigma-Tau Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Co","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017726","name":"Fondazione Diabete Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim Pharma GmbH und Co KG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejim.2024.05.034","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T03:10:45Z","timestamp":1717643445000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Relationship between degree of risk factor control and all-cause mortality in individuals with type 2 diabetes: A prospective cohort study"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2518-3187","authenticated-orcid":false,"given":"Monia","family":"Garofolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2834-4847","authenticated-orcid":false,"given":"Giuseppe","family":"Penno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Solini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4856-7279","authenticated-orcid":false,"given":"Martina","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Resi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6630-2031","authenticated-orcid":false,"given":"Cecilia","family":"Fondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Vedovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Nicolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1574-0397","authenticated-orcid":false,"given":"Giuseppe","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2024.05.034_bib0001","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.05.034_bib0002","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCULATIONAHA.108.829176","article-title":"Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005","volume":"119","author":"Preis","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2024.05.034_bib0003","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2337\/dc11-1162","article-title":"Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey","volume":"35","author":"Gregg","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2024.05.034_bib0004","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00125-013-3063-1","article-title":"Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study","volume":"56","author":"Lind","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejim.2024.05.034_bib0005","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Anon","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2024.05.034_bib0006","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/diabetes.52.5.1210","article-title":"Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older","volume":"52","author":"Alexander","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ejim.2024.05.034_bib0007","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.05.034_bib0008","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.05.034_bib0009","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2024.05.034_bib0010","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2024.05.034_bib0011","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ejim.2024.05.034_bib0012","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejim.2024.05.034_bib0013","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.05.034_bib0014","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/CIRCULATIONAHA.120.046783","article-title":"Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings","volume":"142","author":"Wright","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2024.05.034_bib0015","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1097\/HJH.0b013e3283495cd6","article-title":"Clinical significance of nonalbuminuric renal impairment in type 2 diabetes","volume":"29","author":"Penno","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejim.2024.05.034_bib0016","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/joim.12073","article-title":"Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study","volume":"274","author":"Penno","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2024.05.034_bib0017","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12916-021-01936-3","article-title":"Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study","volume":"19","author":"Penno","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.ejim.2024.05.034_bib0018","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1093\/ndt\/gfr140","article-title":"Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) study","volume":"26","author":"Pugliese","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2024.05.034_bib0019","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s00125-018-4691-2","article-title":"Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study","volume":"61","author":"Penno","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejim.2024.05.034_bib0020","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.2337\/dc12-0628","article-title":"Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study","volume":"35","author":"Penno","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2024.05.034_bib0021","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/dc11-1380","article-title":"Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study","volume":"35","author":"Solini","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2024.05.034_bib0022","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/dom.13306","article-title":"Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes","volume":"20","author":"Orsi","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ejim.2024.05.034_bib0023","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2024.05.034_bib0024","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00592-018-1133-z","article-title":"Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study","volume":"55","author":"Penno","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.ejim.2024.05.034_bib0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(09)61969-3","article-title":"Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study","volume":"375","author":"Currie","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2024.05.034_bib0026","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jacc.2013.04.031","article-title":"Glycemic control and risk of cardiovascular disease hospitalization and all-cause mortality","volume":"62","author":"Nichols","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2024.05.034_bib0027","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/dc10-2377","article-title":"Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study","volume":"34","author":"Huang","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2024.05.034_bib0028","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/08037051.2020.1855968","article-title":"Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension","volume":"30","author":"Olsen","year":"2021","journal-title":"Blood Press"},{"key":"10.1016\/j.ejim.2024.05.034_bib0029","doi-asserted-by":"crossref","first-page":"e2160","DOI":"10.1097\/MD.0000000000002160","article-title":"High Blood Pressure and All-Cause and Cardiovascular Disease Mortalities in Community-Dwelling Older Adults","volume":"94","author":"Wu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2024.05.034_bib0030","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0140-6736(16)31326-5","article-title":"Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study","volume":"388","author":"Vidal-Petiot","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2024.05.034_bib0031","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/jcm9010246","article-title":"Association between on-treatment haemoglobin A1c and all-cause mortality in individuals with type 2 diabetes: importance of personalized goals and type of anti-hyperglycaemic treatment","volume":"9","author":"Orsi","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2024.05.034_bib0032","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1111\/dom.13469","article-title":"Glycaemic control and mortality in older people with type 2 diabetes: the Fremantle Diabetes Study Phase II","volume":"20","author":"Bruce","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ejim.2024.05.034_bib0033","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/HJH.0b013e32832d7370","article-title":"Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study","volume":"27","author":"Sleight","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejim.2024.05.034_bib0034","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1093\/eurheartj\/ehq328","article-title":"J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial","volume":"31","author":"Bangalore","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2024.05.034_bib0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12916-019-1313-x","article-title":"Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study","volume":"17","author":"Solini","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.ejim.2024.05.034_bib0036","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","article-title":"Excess mortality among persons with type 2 diabetes","volume":"373","author":"Tancredi","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.05.034_bib0037","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12933-022-01712-4","article-title":"Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care","volume":"21","author":"Morieri","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejim.2024.05.034_bib0038","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/ndt\/gft506","article-title":"Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes","volume":"29","author":"De Cosmo","year":"2014","journal-title":"Nephrol Dial Transplant"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052400236X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052400236X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T11:08:27Z","timestamp":1742036907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362052400236X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":38,"alternative-id":["S095362052400236X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.05.034","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between degree of risk factor control and all-cause mortality in individuals with type 2 diabetes: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}